# Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir

> **NCT00031486** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 91 (actual)

## Conditions studied

- Encephalitis

## Interventions

- **DRUG:** Valacyclovir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00031486
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2010-06
- **Final completion:** 2011-02
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2012-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031486, "Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00031486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*